Allopurinol Normalizes Endothelial Dysfunction in Type 2 Diabetics With Mild Hypertension
Top Cited Papers
Open Access
- 1 March 2000
- journal article
- other
- Published by Wolters Kluwer Health in Hypertension
- Vol. 35 (3) , 746-751
Abstract
—Therapeutic strategies against free radicals have mostly focused on the augmentation of antioxidant defenses (eg, vitamins C and E). A novel approach is to prevent free radical generation by the enzyme system xanthine oxidase. We examined whether the inhibition of xanthine oxidase with allopurinol can improve endothelial function in subjects with type 2 diabetes and coexisting mild hypertension compared with control subjects of a similar age. We examined 23 subjects (11 patients with type 2 diabetes and 12 healthy age-matched control subjects) in 2 parallel groups. The subjects were administered 300 mg allopurinol in a randomized, placebo-controlled study in which both therapies were administered for 1 month. Endothelial function was assessed with bilateral venous occlusion plethysmography, in which the forearm blood flow responses to intra-arterial infusions of endothelium-dependent and -independent vasodilators were measured. Allopurinol significantly increased the mean forearm blood flow response to acetylcholine by 30% (3.16±1.21 versus 2.54±0.76 mL · 100 mL −1 · min −1 allopurinol versus placebo; P =0.012, 95% CI 0.14, 1.30) but did not affect the nitroprusside response in patients with type 2 diabetes. There was no significant impact on either endothelium-dependent or -independent vascular responses in age-matched control subjects. Allopurinol improved endothelial function to near-normal levels. Regarding markers of free radical activity, the level of malondialdehyde was significantly reduced (0.30±0.04 versus 0.34±0.05 μmol/L for allopurinol versus placebo, P =0.03) in patients with type 2 diabetes but not in control subjects. The xanthine oxidase inhibitor allopurinol improves endothelial dysfunction in patients with type 2 diabetes with mild hypertension but not in matched control subjects. In the former group, allopurinol restored endothelial function to near-normal levels.Keywords
This publication has 28 references indexed in Scilit:
- Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1996
- Reduction of reperfusion injury of human myocardium by allopurinol: A clinical studyFree Radical Biology and Medicine, 1995
- Pretreatment with antioxidants and allopurinol diminishes cardiac onset events in coronary artery bypass graftingThe Annals of Thoracic Surgery, 1995
- Effect of Long-Term Angiotensin-Converting Enzyme Inhibition on Endothelial Function in Patients with the Insulin-Resistance SyndromeJournal of Cardiovascular Pharmacology, 1995
- Allopurinol-Enhanced Postischemic Recovery in the Isolated Pat Heart Involves Repletion of High-Energy PhosphatesBiochemical Medicine and Metabolic Biology, 1994
- Lack of cardioprotective efficacy of allopurinol in coronary artery surgery.Heart, 1994
- The Relationship of Oxidative Stress to Thrombotic Tendency in Type 1 Diabetic Patients with RetinopathyDiabetic Medicine, 1991
- Influence of allopurinol on cardiac complications in open heart operationsThe Annals of Thoracic Surgery, 1991
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988
- Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factorNature, 1986